SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean Public Health Institute (Instituto de Salud Pública, ISP) approved a phase II clinical trial for its inactivated Omicron strain COVID-19 vaccine and trivalent COVID-19 vaccine (ancestral, Delta and Omicron variants) on August 31st. The clinical trial will evaluate the immunogenicity and safety of one booster dose of the two candidate vaccines in adults who had received two booster doses of CoronaVac®, mRNA, or adenovirus vector COVID-19 vaccine. This study is the world's first study researching multivalent inactivated COVID-19 vaccine.
In this phase II randomized, double-blind, multicenter clinical trial, 826 fully vaccinated adults will be recruited. Participants belonging to the heterologous scheme are individuals who had received two CoronaVac® doses, and two boosters of mRNA-based or viral vector-based vaccines, while participants of the homologous scheme had received four doses of CoronaVac®. Individuals from the heterologous scheme will randomly receive a booster dose with the Omicron, Trivalent, or CoronaVac® vaccines, while individuals from the homogeneous group will randomly receive a booster dose of the Omicron or the trivalent vaccines.
Mr. Weidong Yin, the Chairman, President, and CEO of SINOVAC said, “SINOVAC has made great progress collaborating with global partners in the development and manufacturing of the COVID-19 vaccine. We are proud of the fact that CoronaVac® can protect individuals as young as 6 months of age and this clinical approval will allow even better vaccine protection.”
Sinovac Biotech Ltd., (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A and B, seasonal influenza, pneumococcal disease, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), varicella, mumps, and poliomyelitis. Its COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. Its Healive®, hepatitis A vaccine, passed WHO prequalification requirements in 2017. Its EV71 vaccine, Inlive®, is an innovative vaccine commercialized in China in 2016. In 2022, SINOVAC’s Sabin-strain inactivated polio vaccine (sIPV) was prequalified by the WHO.
SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program.
SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations.
For more information, please see the Company’s website at www.sinovac.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Sinovac Biotech Ltd.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Capitolis to Present at TradeTech FX 202227.9.2022 20:10:00 CEST | Press release
Capitolis, the technology company reimagining financial markets, will join TradeTech FX, the largest buy side FX event in Europe. This is the first year Capitolis will have a presence on the ground at the event. Ben Tobin, Capitolis SVP, Head of Europe/Portfolio Optimization, will join a panel of FX industry leaders on Wednesday, 9/27, at 12:55 local time to discuss how uncleared margin rules (UMR) and the Standardized Approach for Counterparty Credit Risk (SA-CCR) have impacted the FX trading desk and market structure – and share predictions for how it could influence other FX products in the future. “We’ve been a partner and provider of optimization services to banks, hedge funds, and real money managers over the past five years,” said Ben Tobin, Capitolis SVP, Head of Europe/Portfolio Optimization. “We’ve already helped our customers reduce trillions of notional since the beginning of 2022, including optimization between the banks and their diverse client base.” TradeTech FX attende
Fintatech Announces Trading Chart Designer 2.027.9.2022 18:32:00 CEST | Press release
Fintatech, a custom trading software development company and provider of high-performance capital market solutions with a universal 'trading platform skeleton' in its core that is supplemented by interconnective module-based software components according to the client’s requirements, announces significant enhancements to their Trading Chart Designer software solution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005640/en/ Fintatech Trading Chart Designer 2.0 Release (Graphic: Business Wire) Our current trading software solutions list is comprised of: - Trading Chart Designer - Trading Platform Designer - Trading Data Server Read on to learn more about our enhancements in Trading Chart Designer 2.0, including: New indicators Traders may use over 130 Technical Analysis Indicators on our platform to do the finest market analysis. We keep researching and adding new indicators, so that traders may make even more precise
Globee® Awards Issues Call for Business Awards Nominations From All Over The World27.9.2022 17:00:00 CEST | Press release
The Globee® Awards, organizer of the world’s premier business awards programs and business ranking lists, is now accepting nominations for the Annual Business Excellence Awards from all over the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005179/en/ Learn more about the Globee Business Awards and how to nominate here: https://globeeawards.com/business-awards/. The coveted annual Globee® Business Excellence Awards program recognizes and honors the world’s best in organizational performance, products and services, innovations, executives and management teams, women in business and the professions, case studies and successful deployments, communications, public relations and marketing campaigns, product management, websites, blogs, white-papers, videos, advertisements, creativity, partner programs, and customer satisfaction programs from every major industry in the world. Individuals and organizations from anywh
Recurly Enhances Revenue Recognition Solution, Helping Subscription Businesses Automate Complex Accounting Processes27.9.2022 16:00:00 CEST | Press release
Recurly, Inc., a leading subscription management and billing platform for high-growth brands, has announced an agreement to acquire LeapRev, a global revenue recognition and forecasting solution. This acquisition will create a single source for subscription management, recurring billing, and revenue management that empowers Recurly customers to better focus on driving growth among increasingly complex and evolving revenue accounting and reporting standards. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005356/en/ Recurly launches enhanced revenue recognition capabilities. (Graphic: Business Wire) “Recurly powers recurring billing management for many of the world’s leading brands. Part of our customers’ success has resulted from Recurly’s ability to support more granular, pay-as-you-go pricing models. This trend toward enabling greater flexibility in pricing models creates a greater need for accounting automation,” sai
Andersen Global Cultivates Additional Presence in East Asia with Law Firm of Lee & Ko27.9.2022 15:30:00 CEST | Press release
Andersen Global strengthens its global presence in East Asia through a non-exclusive Collaboration Agreement with the full-service law firm Lee & Ko, extending the global organization’s reach into South Korea. Founded in 1977, Lee & Ko is one of the oldest firms in South Korea with more than 800 professionals and 300 Partners. The firm provides clients with full service across its eight major practice groups: antitrust and competition, banking and finance, corporate and M&A, intellectual property, labor and employment, litigation and arbitration, tax and customs, and white-collar crimes. Lee & Ko is consistently recognized as a Tier 1 firm by organizations, including Asialaw, IFLR1000, Legal 500 Asia-Pacific, Chambers & Partners Asia-Pacific, among others. “Throughout our firm’s history, we’ve grown to be widely recognized as a leading firm that provides clients with best-in-class service and comprehensive legal coverage,” Senior Partner Hyeong Gun Lee said. “As a collaborating firm of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom